17 August 2020: Clinical Research
Evaluation of Ovarian Tumors with Multidetector Computed Tomography and Tumor Markers: Differentiation of Stage I Serous Borderline Tumors and Stage I Serous Malignant Tumors Presenting as Solid-Cystic Mass
Xin-Ping Yu 1BCE , Ying Liu 2C , Jin-Wen Jiao 1D , Hong-Juan Yang 1B , Rui-Jing Wang 1D , Shuai Zhang 3ACF*DOI: 10.12659/MSM.924497
Med Sci Monit 2020; 26:e924497
Table 6 The interobserver reproducibility of MDCT features.
| MDCT feature | κ | ICC |
|---|---|---|
| Location | 1.000 | – |
| Tumor shape | 0.754 | – |
| Margins | 0.781 | – |
| Texture | 0.800 | – |
| Papillary projections | 0.882 | – |
| Papillary projections with papillary surface | 0.697 | – |
| Discontinuous septa | 0.821 | – |
| Ascites | 0.961 | – |
| Vascular abnormalities | 0.900 | – |
| Maximum thickness of wall (mm) | – | 0.854 |
| Maximum thickness of septa (mm) | – | 0.749 |
| Maximum diameter of solid component (mm) | – | 0.845 |
| MDCT – multidetector computed tomography; κ – kappa; ICC – intraclass correlation coefficient; SBOTs – serous borderline ovarian tumors; SMOTs – serous malignant ovarian tumors. | ||